These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28670327)

  • 21. Salbutamol delivery from a hydrofluoroalkane pressurized metered-dose inhaler in pediatric ventilator circuits: an in vitro study.
    Wildhaber JH; Hayden MJ; Dore ND; Devadason SG; LeSouëf PN
    Chest; 1998 Jan; 113(1):186-91. PubMed ID: 9440589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pressurised metered dose inhalers versus all other hand-held inhaler devices to deliver beta-2 agonist bronchodilators for non-acute asthma.
    Ram FS; Brocklebank DM; White J; Wright JP; Jones PW
    Cochrane Database Syst Rev; 2002; 2002(1):CD002158. PubMed ID: 11869625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients.
    Dusser D; Vicaut E; Lefrançois G;
    Respiration; 2005; 72 Suppl 1():20-7. PubMed ID: 15915009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and performance of a new hydrofluoroalkane (HFA 134a)-based metered dose inhaler (MDI) of salmeterol.
    Peyron ID; Britto IL; Benissan LB; Tardieu BZ
    Respir Med; 2005 Apr; 99 Suppl A():S20-30. PubMed ID: 15777605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced Environmental Impact of the Reusable Respimat
    Hänsel M; Bambach T; Wachtel H
    Adv Ther; 2019 Sep; 36(9):2487-2492. PubMed ID: 31317391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, double-blind, double-dummy, single-dose, efficacy crossover trial comparing formoterol-HFA (pMDI) versus formoterol-DPI (Aerolizer) and placebo (pMDI or Aerolizer) in asthmatic patients.
    Bousquet J; Huchon G; Leclerc V; Vicaut E; Lefrançois G
    Respiration; 2005; 72 Suppl 1():6-12. PubMed ID: 15915007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of hydrofluoroalkane propellant delivery system for inhaled albuterol in patients receiving asthma medications.
    Boccuzzi SJ; Wogen J; Roehm JB
    Clin Ther; 2000 Feb; 22(2):237-47. PubMed ID: 10743983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delay Between Shaking and Actuation of a Hydrofluoroalkane Fluticasone Pressurized Metered-Dose Inhaler.
    Berlinski A; von Hollen D; Pritchard JN; Hatley RH
    Respir Care; 2018 Mar; 63(3):289-293. PubMed ID: 29162718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Interval Between Actuations of Albuterol Hydrofluoroalkane Pressurized Metered-Dose Inhalers on Their Aerosol Characteristics.
    Berlinski A; Pennington D
    Respir Care; 2017 Sep; 62(9):1123-1130. PubMed ID: 28611228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Equivalent asthma control and systemic safety of inhaled budesonide delivered via HFA-134a or CFC propellant in a broad range of doses.
    Grzelewska-Rzymowska I; Malolepszy J; de Molina M; Sladek K; Zarkovice J; Siergiejko Z;
    Respir Med; 2003 Nov; 97 Suppl D():S10-9. PubMed ID: 14753247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Randomized Controlled Trial of 2 Inhalation Methods When Using a Pressurized Metered Dose Inhaler With Valved Holding Chamber.
    Stephen D; Vatsa M; Lodha R; Kabra SK
    Respir Care; 2015 Dec; 60(12):1743-8. PubMed ID: 26081179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Equivalence of as-required salbutamol propelled by propellants 11 and 12 or HFA 134a in mild to moderate asthmatics. German Study Group.
    Baumgarten CR; Dorow P; Weber HH; Gebhardt R; Kettner J; Sykes AP
    Respir Med; 2000 Jun; 94 Suppl B():S17-21. PubMed ID: 10919681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhaled beclomethasone (BDP) with non-CFC propellant (HFA 134a) is equivalent to BDP-CFC for the treatment of asthma.
    Milanowski J; Qualtrough J; Perrin VL
    Respir Med; 1999 Apr; 93(4):245-51. PubMed ID: 10464888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro performance of two common valved holding chambers with a chlorofluorocarbon-free beclomethasone metered-dose inhaler.
    Asmus MJ; Coowanitwong I; Kwon SH; Khorsand N; Hochhaus G
    Pharmacotherapy; 2003 Dec; 23(12):1538-44. PubMed ID: 14695033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic equivalence of inhaled beclomethasone dipropionate with CFC and non-CFC (HFA 134a) propellants both delivered via the Easibreathe inhaler for the treatment of paediatric asthma.
    Farmer IS; Middle M; Savic J; Perri VL; Herdman MJ
    Respir Med; 2000 Jan; 94(1):57-63. PubMed ID: 10714480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cumulative dose-response study of non-CFC propellant HFA 134a salbutamol sulfate metered-dose inhaler in patients with asthma.
    Kleerup EC; Tashkin DP; Cline AC; Ekholm BP
    Chest; 1996 Mar; 109(3):702-7. PubMed ID: 8617079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In Vitro Evaluation of Aerosol Performance and Delivery Efficiency During Mechanical Ventilation Between Soft Mist Inhaler and Pressurized Metered-Dose Inhaler.
    Ke WR; Wang WJ; Lin TH; Wu CL; Huang SH; Wu HD; Chen CC
    Respir Care; 2020 Jul; 65(7):1001-1010. PubMed ID: 32071134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oronasal and Tracheostomy Delivery of Soft Mist and Pressurized Metered-Dose Inhalers With Valved Holding Chamber.
    Berlinski A; Cooper B
    Respir Care; 2016 Jul; 61(7):913-9. PubMed ID: 27006348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Budesonide administered using chlorofluorocarbon and hydrofluoroalkane pressurized metered-dose inhalers: pharmacokinetics, pharmacodynamics and clinical equivalence.
    Singh D; Tutuncu A; Lohr I; Carlholm M; Polanowski T
    Int J Clin Pharmacol Ther; 2007 Sep; 45(9):485-95. PubMed ID: 17907591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aerosol devices and asthma therapy.
    Berger W
    Curr Drug Deliv; 2009 Jan; 6(1):38-49. PubMed ID: 19418954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.